Trial Profile
A Phase Ⅲ Randomized Double-Blind Placebo-Controlled Study of Epoetin Beta for the Treatment of Chemotherapy-Induced Anemia (CIA) in Cancer Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs Epoetin beta (Primary)
- Indications Chemotherapy-induced anaemia
- Focus Registrational; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 03 Jun 2014 New trial record